Figure 1.
Cost of detecting highly significant extracolonic lesions. Cost-effectiveness was assessed using the following calculation for each group. Poor cost-effectiveness in the detection of highly significant lesions was observed for subjects aged below 60 year-old (US $ 3442), subjects without symptoms (US $ 3737), and CT colonography performed without contrast enhancement (US $ 4221).